Alignment Healthcare, Inc. (ALHC)

Nasdaq Health Care Health Care Services S&P SmallCap 600
$7.34
-0.22 (-2.91%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$0.13
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 29, 2026Sep/2026$-0.04$-0.04—

Our record of ALHC's reports since we began tracking; it grows each quarter.

Latest results, in brief

All ALHC 8-K briefs →
Oct 29, 4:01 PM ET

Alignment Healthcare Q3 revenue up 36.7%, but net loss and lower 2026 profit guidance

Mixed guidance 2.02

Alignment Healthcare reported third-quarter 2026 total revenue of $1,358.3 million, up 36.7% year-over-year, and membership of approximately 301,200, up 31.2%. Profit fell, with a net loss of $8.1 million compared with net income of $3.7 million a year earlier, and adjusted EBITDA down 32.8%. The company lowered its full-year 2026 adjusted gross profit and adjusted EBITDA guidance because of higher medical costs, which weighs on shareholders' expectations for profitability.

  • Q3 2026 total revenue was $1,358.3 million, up 36.7% year-over-year; net loss was $8.1 million versus net income of $3.7 million a year earlier
  • Medical benefits ratio based on adjusted gross profit rose to 89.5%, an increase of approximately 240 basis points year-over-year
  • Full-year 2026 adjusted gross profit guidance is no less than $575 million and adjusted EBITDA guidance is no less than $100 million, both lowered; full-year revenue guidance was raised to no less than $5,245 million
  • Fourth-quarter 2026 guidance calls for adjusted EBITDA of $(28) million, a loss, on revenue of $1,316 million
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$1.36B+36.7% $-0.04-300.0% -$8.05M-0.6%
Jun 2026$1.34B+31.6% $0.17+142.9% $36.56M2.7%
Mar 2026$1.24B+33.3% $0.05— $11.42M0.9%
Dec 2025$1.01B+44.4% $-0.05— -$11.01M-1.1%
Sep 2025$993.70M+43.5% $0.02— $3.73M0.4%
Jun 2025$1.02B+49.0% $0.07— $15.67M1.5%
Mar 2025$926.93M+47.5% $-0.05— -$9.11M-1.0%
Dec 2024$701.24M+52.8% $-0.16— -$31.09M-4.4%

From Alignment Healthcare, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$3.95B+46.1% $0.00—-0.0%
FY2024$2.70B+50.1% $-0.67—-4.7%
FY2023$1.80B+25.8% $-0.79—-8.2%
FY2022$1.43B+22.7% $-0.83—-10.4%
FY2021$1.17B+22.2% $-1.14—-16.7%

Frequently asked questions

When is Alignment Healthcare's next earnings date?

Alignment Healthcare has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Alignment Healthcare earn last quarter?

For the quarter ended Sep 2026, Alignment Healthcare reported diluted EPS of $-0.04 (-300.0% year over year) on revenue of $1.36B (+36.7%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.